Professional Marketing briefs: December 2013

Eisai
Eisai

Eisai's legal maneuver to pressure the Drug Enforcement Agency to schedule the company's FDA-approved epilepsy drug has failed. BioCentury ­reports that the District of Columbia's US Court of Appeals will not compel the DEA to put the seizure medication, Fycompa, on a schedule within a given time frame. Without a designated schedule, Eisai cannot put the drug on the market, though its patent life continues to wind down.

Vivus's tumultuous year continues. The company is cutting 17% of it its workforce, which amounts to around 20 employees. Of note: ­Vivus says the the cuts will have no effect on its 150-person sales force.

An FDA advisory committee gave a 9-2 thumbs-down for expanding the indication for Amarin's fish-oil product Vascepa. ­The drug is approved for patients with severe hypertriglyceridemia, and the company seeks to expand its patient reach to include patients with elevated triglycerides. Jefferies analyst Thomas Wei wrote in his Oct. 17 research note that the panel's decision was a “Major Negative” for Amarin and the delay increases potential competition from generic Lovaza in 2015. Wei puts Vascepa's value at $1 per share if it fails to get an expanded ­indication.

You must be a registered member of MMM to post a comment.

Email Newsletters


As US pharma continued its quest for a Grand Prix at the Lions Health international festival of creativity, MM&M went on location to Cannes, France. Missed our coverage from June? Now, we're giving you an opportunity to catch up on some of what you missed. Download our e-book on the two-day festival, recapping the event, rounding up the best of the speakers, offering perspective and listing all of the winners. Click here to download.


The most recent MM&M Skill Sets Live event surveyed a range of issues relating to one of the hottest promotional spaces in healthcare. Speakers and panelists at the morning-long session, including promotional- and multichannel-minded executives from GSK, Epocrates, Treato and Montefiore Medical Center, weighed in on topics designed to help marketers demystify the challenges associated with non-personal promotion. Click here.